LESSONS FROM EVIDENCE BASED MEDICINEIN THE CARE OF ARF AND ESRD. Prof. Dr. Adrian Covic University of Medicine Gr. T. Popa, Iaşi
|
|
|
- Victor Ward
- 5 years ago
- Views:
Transcription
1 LESSONS FROM EVIDENCE BASED MEDICINEIN THE CARE OF ARF AND ESRD 2008 Prof. Dr. Adrian Covic University of Medicine Gr. T. Popa, Iaşi
2 Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients Metnitz PG et al. Crit Care Med Sep;30(9): ARF associated with four-fold increased mortality Mortality significantly higher in ARF patients (62.8 vs. 38.5%)
3 Myth 1 mortality in ARF remains unchanged? % 92% Mortality 54% Mortality :53% Sf Ioan BOTEZATORUL Ricci, Ronco Crit Care Clin 21: ,2005
4 Proportion of old pts. (> 80 yrs.) with ARF in ICU 50 Procent de varstnici din numarul total IRA Ani Akposso et al Intens Care Med 26: ,2000
5
6 FIRST CONCLUSION : WE TREAT BETTER AND RESULTS WILL PROBABLY SHOW UP
7 MYTH 2 Who is responsible for the RRT? N= 5887 Nephrology Intensivist 10 0 Nephrologist Intensivist Both Gambro Dialysis Opinions 2005
8 A SIMPLE EXPLANATION...Intensivists are intensively managing many things at the time.
9 WHILE A NEPHROLOGIST IS THINKING
10 Nephrology Consultation in ARF: Does Timing Matter? Mehta R et al. Am. J. Med. 2002; 113:
11
12 WHY? Early goal-directed therapy in the treatment of severe sepsis and septic shock (Rivers et al. N. Eng. J. Med. 2001; 345 : ) Early goal Standard therapy therapy (n = 130) (n = 130) MODS* Baseline 7.6 ± ± h 5.9 ± ± 3.7 p < h 5.1 ± ± 4 p < Mortality 30.5 % 46.5 % p < 0.01
13
14 2-nd CONCLUSION: TEAMWORK, BUT, NEPHROLOGIST FROM THE VERY START Manager Nephrologist cardiologist nutritionist radiology, ultrasound anesthesist PROFESSOR Lab. Surgeon Head nurse Intensivist fellow
15 Myth 3 Renal-dose Dopamine Or IDEAL vssopressor agent
16 Use of dopamine in ARF: a meta-analysis Plot showing relative risks (diamonds) and 95% confidence intervals (lines) for all studies and for subgroups A,B, and C. A Lauschke et al A:excluding studies using contrast B: Studies limited to heart disease C: excluded statistical outliers Kidney International (2006) 69, 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure Kellum and Decker Crit Care Med 29: ,2001
17 Potential solutions: Fenoldopam-risk of AKI in critically ill Landoni et al, AJKD 49:56-68, 2006.
18 Prevention of vasoconstriction Fenoldopam dopamine A-1 receptor agonist Systematic review of RCTs in ICU or major surgery 16 studies, 1290 patients Reduced risk of acute kidney injury OR 0.43 ( ) Reduced need for RRT OR 0.54 ( ) Reduced in hospital death OR 0.64 ( )
19 NOREPINEPHRINE in patients with AKI Bellomo et al, Crit Care Med, 2008
20 NOREPINEPHRINE in patients with AKI Leone et al, Current Opinion in Anesthesiology, 2008
21 Patient survival Survival of septic shock patients treated with vasopressors Norepinephrine Other vasopressors Martin et al Crit Care Med, 28: , 2000 Hospitalisation days
22 Norepinephrine vs Terlipressine in septic shock Albanese et al, Crit Care 2005 Vasopressin: -Strong splanchnic vasoconstriction -Eferent glomerular vasoconstriction -Deficient in many shock patients
23 3-rd CONCLUSION: NOREPINEPHRINE AND NOT DOPAMINE Norepinephrine dose (mg/kg/min) < >0.3 Mortality (%)
24 Myth 4 FILLING MOST IMPORTANTLY IDEAL SOLUTION
25 Use of Pulmonary artery Catheter 20 %of cases need for RRT PAC catheter complications CVC NEJM, 2006, 354, 2213
26 Clinical evaluation of intravascular filling status N=71, nonspontaneous breathing patients Monnet et al, Critical Care Medicine, 2006
27 Conservative vs liberal fluid loading in ARDS patients POSSIBLY BETTER FOR THE LUNGS NEJM 2006, 354, 2564
28 SAFE study N Engl J Med 2004;350: SURVIVAL: albumin VS saline
29 Global mortality risk in the «SAFE» study in critically ill patients (albumin vs isotonic saline) SAFE study N Engl J Med 2004;350:
30 Fluids in ICU Cochrane survey march 2007 Albumin vs HES (24 trials): RR 1.14 ( ) Albumin vs gelatine (7 trials): RR: 0.97 ( ) Albumin vs Dextran (4 trials): RR.3.75 ( ) Gelatin vs HES: (18 trials): RR: 1.0 ( ) Conclusion: no difference!! Bunn et al, Cochrane database, 2008
31 Fluid type and outcome Brunkhorst et al, NEJM 2008
32 Brunkhorst et al, NEJM 2008
33 Brunkhorst et al, NEJM 2008
34 Timing of correction of tissue perfusion on outcome Boldt et al, Crit Care 2002
35 4-th CONCLUSION: SALINE, CVP + GOOD CLINICAL PRACTICE, POSIBIL RINGER MACROMOLECULAR SOLUTIONS
36 MYTH 5 FUROSEMID COMPULSORY?
37 Loop Diuretics and ARF: double-blind, randomized trial Percent Shilliday et al. Nephrol Dial Transplant 11,1684,1996.
38 Loop Diuretics and ARF: double-blind, randomized trial Mehta et al JAMA 288: , 2002
39 Diuretics and outcome of AKI - metaanalysis Sampath et al, Crit Care Med, 2007
40 5-th CONCLUSION: FUROSEMID PROBABLY, but AFTER CORRECT FILLING (!)
41 PROMISSES OR CERTITUDES? 1. Insulin intensive glycaemic control 2. EPO 3. Activated Protein C 4. Steroids 5. Atrial Natriuretic Factor - ANF 6. Growth factors - IGF I; Endothelin antagonist receptors; Tyroxin; PGE 1
42 1) Effect of control of mean blood glucose in ICU patients > < 110 Van den Berghe et al Crit Care Med 2003, 31: Percentage of risk for several complications in ICU patients with stay > 5 days Cumulative risk of hospital death in ICU patients with stay> 5 days
43 Survival: intensive insulin therapy or conventional insulin therapy in severe sepsis Brunkhorst et al, N Engl J Med 2008;358:
44 2) EPO: Cumulative patient survival in critically ill patients EPO: n 733 Control: n 722 Corwin et al, N Engl J Med 2007; 357:
45
46 Coagulation Anticoagulant Procoagulant TM - thrombin PC ATIII TFPI APC + PS COAGULATION Degrades Va, VIIIa T-ATIII complexes (-) (-) Thrombin Xa IXa Prothrombin X IX VIIa TF
47 APC Therapy for Patients with Septic Shock 24.7% 30.8% 19.4% relative red n
48 Hydrocortisone Therapy for Patients with Septic Shock Kaplan Meier Curves for Survival at 28 Days. Sprung et al, N Engl J Med 2008;358:
49 Anaritide: 21-Day Dialysis-Free Survivorship. % * p=0.005 A vs. P Lewis et al, AJKD 2000
50 This machine brings everything in shape!
51 When to initiate acute dialysis? Generally accepted indications Acute (life-threatening) hyperkalemia Severe volume overload (pulmonary edema) Severe metabolic acidosis Uremic organ complications (e.g. pericarditis) Prophylactic dialysis: Creatinine clearance, e.g ml/kg/min? Serum urea concentrations, e.g. 150, 200,... mg/dl?
52 Retrospective analysis (100 trauma patients, ) Early : BUN<60 mg/dl; late : BUN> 60 mg/dl Early starters had significantly better survival compared to late starters: 39% vs. 20.3% (p=0.041) A. Jörres
53 Timing of initiation of RRT and prognosis in AKI-PICARD group RR for death (CI)* RR for death (CI)** RR for death (CI)*** Low BUN at start RRT < 76 mg/dl High BUN at start RRT ( ) ( ) ( ) > 76 mg/dl Adjusted for age, hepatic failure, sepsis, thrombocytopenia,and serum creatinine and stratified by site and initial dialysis modality, ** Adjusted for propensity score alone *** Adjusted for co)variates and propensity score Liu et al cjasn 1: , 2006.
54 Treatment practices in RRT for AKI Overberger et al, cjasn,2008
55 Daily HD and prognosis of patients with ARF Schiffl et al NEJM 346: , 2002
56 Mortality in CVVH patients is related to the volume of replacement fluid Prospective RCT of different doses in CVVH treatment of ARF 425 patients Primary endpoint: days after stopping CVVH Significantly better survival with 35 or 45 ml/kg/min vs. 20 ml/kg/min Ronco et al, Lancet 2000; 356: 26-30
57 Outcome CRRT vs IHD % P= 0.02 P=0.02 N= All CRRT IHD 10 0 ICU mortality Hospital mortality Mehta et al, Kidney Int, 2001,
58 Survival IHD vs CRRT A randomised controlled trial DAILY TREATMENT Vinsonneau et al, Lancet 2006, Hemodaife
59 Survival IHD vs CRRT A randomised controlled trial Vinsonneau et al, Lancet 2006, Hemodaife
60 CRRT vs IHD: The PICARD experience Cho et al, JASN november 2006
61 IHD vs CRRT: a meta analysis Bagshaw et al, Crit Care Med, 2008
62 Cartoon Stolen from An De Vriese
63 CVVHD vs. IHD for RRT in ICU Conclusion: These data suggest that, provided strict guidelines to improve tolerance and metabolic control are used, almost all patients with acute renal failure as part of multipleorgan dysfunction syndrome can be treated with intermittent haemodialysis Vinsonneau et al, Lancet 2006; 368:
64 SLEDD vs CVVH: a randomised controlled trial Kielstein et al, AJKD 2004
65 The Genius dialysis System
66 ... What else is important: Dialysis dose K t V M.D. t P
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes Richard Beale RIFLE classification (ADQI group) 2004 Outcome AKIN classification Definition: Abrupt (within 48 hrs)
Update in Critical Care Medicine
Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update
Decision making in acute dialysis
Decision making in acute dialysis Geoffrey Bihl MB.BCh M.MED FCP(SA) Nephrologist and Director Winelands Kidney and Dialysis Centre Somerset West South Africa Important questions in AKI What is the cause?
Fluid Management in Critically Ill AKI Patients
Fluid Management in Critically Ill AKI Patients Sang Kyung Jo, MD, PhD Department of Internal Medicine Korea University Medical College KO/MG31/15-0017 Outline Fluid balance in critically ill patients:
Renal Replacement Therapy in Acute Renal Failure
CHAPTER 82 Renal Replacement Therapy in Acute Renal Failure R. Deshpande Introduction Acute renal failure (ARF) is defined as an abrupt decrease in renal function sufficient to result in retention of nitrogenous
Who? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011
Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011 Dorre Nicholau MD PhD Clinical Professor Department of Anesthesia and Perioperative Care University of
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement
Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement Prof. Dr. Achim Jörres Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum
Managing Patients with Sepsis
Managing Patients with Sepsis Diagnosis; Initial Resuscitation; ARRT Initiation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum
ASN Board Review: Acute Renal Replacement Therapies
ASN Board Review: Acute Renal Replacement Therapies Ashita Tolwani, M.D., M.Sc. University of Alabama at Birmingham 2014 Key issues for boards: RRT for AKI When should therapy be initiated? What are the
Evidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy
Controversies in Hospital Medicine: Critical Care Vasopressors, Steroids, and Insulin Therapy Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado Denver Clinical Specialist in Critical
Renal failure in sepsis and septic shock
Renal failure in sepsis and septic shock Dr. Venugopal Reddy. MD, EDIC, FCARCSI Associate Professor of Anesthesiology and Critical Care medicine Department of Anaesthesia and CCM Penn State College of
Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis
Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? A common condition in ICU patients Associated with high mortality and morbidity Renal Replacement Therapy (RRT) is the cornerstone
Section 3: Prevention and Treatment of AKI
http://www.kidney-international.org & 2012 KDIGO Summary of ommendation Statements Kidney International Supplements (2012) 2, 8 12; doi:10.1038/kisup.2012.7 Section 2: AKI Definition 2.1.1: AKI is defined
Acute Kidney Injury. Amandeep Khurana, MD Southwest Kidney Institute
Acute Kidney Injury Amandeep Khurana, MD Southwest Kidney Institute 66 yr white male w/ DM, HTN, CAD admitted to an OSH w/ E Coli UTI on 7/24/16, developed E Coli bacteremia and Shock (on vaso + levo)
Olistic Approach to Treatment Adequacy in AKI
Toronto - Canada, 2014 Olistic Approach to Treatment Adequacy in AKI Claudio Ronco, MD Department of Nephrology, St. Bortolo Hospital, International Renal Research Institute Vicenza - Italy 1) RRT
Paul R. Bowlin, M.D. University of Colorado Denver. May 12 th, 2008
Paul R. Bowlin, M.D. University of Colorado Denver May 12 th, 2008 Presentation Overview Background / Definitions History Indications for initiation of therapy Outcomes Studies Conclusions Questions Background
Comparing RRT Modalities: Does It Matter What You Use If The Job Is Done?
Comparing RRT Modalities: Does It Matter What You Use If The Job Is Done? Sean M Bagshaw, MD, MSc Division of Critical Care Medicine University of Alberta Disclosure Consulting: Alere, Baxter, Gambro,
CRRT: The Technical Questions Modality & Dose. Ashita J. Tolwani, MD, MSc University of Alabama at Birmingham 2018
CRRT: The Technical Questions Modality & Dose Ashita J. Tolwani, MD, MSc University of Alabama at Birmingham 2018 Case A 24YOM with HTN and OSA presents with acute pancreatitis. Despite aggressive fluid
Acute Kidney Injury Is there a Best Practice?
Acute Kidney Injury Is there a Best Practice? M I T C H E L L R O S N E R, M D C h a i r m a n, D e p a r t m e n t o f M e d i c i n e U n i v e r s i t y o f V i r g i n i a H e a l t h S y s t e m Disclosures
Resuscitation fluids in critical care
Resuscitation fluids in critical care John A Myburgh MBBCh PhD FCICM UNSW Professor of Critical Care Medicine The George Institute for Global Health University of New South Wales St George Hospitals, Sydney
ECMO & Renal Failure Epidemeology Renal failure & effect on out come
ECMO Induced Renal Issues Transient renal dysfunction Improvement in renal function ECMO & Renal Failure Epidemeology Renal failure & effect on out come With or Without RRT Renal replacement Therapy Utilizes
Dialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012
Dialysis Dose Prescription and Delivery William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012 Dose in RRT: Key concepts Dose definition Quantifying
Update in Nephrology. Case: Question 1. Case presentation. Acute Kidney Injury. For her hypertension management, you decide to:
Update in Nephrology Chronic Kidney Disease Renoprotection and Proteinuria, ACE and/or ARB Anemia management Update in Nephrology Renal artery stenosis Nephrogenic systemic fibrosis Division of Nephrology
When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen
When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen Case history (1) 64 Hypertension 2004 AVR 2009 Paravalvular leak - dilated
Acute Liver Failure: Supporting Other Organs
Acute Liver Failure: Supporting Other Organs Michael A. Gropper, MD, PhD Professor of Anesthesia and Physiology Director, Critical Care Medicine University of California San Francisco Acute Liver Failure
Renal Replacement Therapy in ICU. Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine
Renal Replacement Therapy in ICU Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine Introduction Need for RRT in patients with ARF is a common & increasing problem in ICUs Leading cause of ARF
CRRT. ICU Fellowship Training Radboudumc
CRRT ICU Fellowship Training Radboudumc Timing RRT Consider the following: Underlying cause and reversibility. Rapid improvement unlikely with high dose vasopressors and continuous exposure to other risk
Acute Kidney Injury- What Is It and How Do I Treat It?
Acute Kidney Injury- What Is It and How Do I Treat It? Jayant Kumar, MD Renal Medicine Assoc., Albuquerque, NM Incidence of ARF in ICU Causes of ARF Non -ICU ICU 1 KDIGO criteria for AKI Increase in serum
Citrate Anticoagulation
Strategies for Optimizing the CRRT Circuit Citrate Anticoagulation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum Berlin, Germany
CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT
CRRT Fundamentals Pre-Test AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling at home. He
What s new in kidneys a renal update for Anaesthetists
What s new in kidneys a renal update for Anaesthetists Thursday 11 th December 2014 Roslyn Simms Clinical Lecturer in Nephrology Renal update What s new/update AKI When to start RRT in AKI? Perioperative
Novel Sepsis Therapies
RSEM-GSA 17 Novel Sepsis Therapies Khaled Ahmed Alghamdi, MD, ABEM, FACEP, FAAEM Consultant Emergency Medicine Deputy program director Medical Director of Emergency Medical Services King Faisal Specialist
Acute Kidney injury 2014
Acute Kidney injury 2014 BWJ van Rensburg Division of Nephrology University of the Free State After > 100 years unable to significantly influence the natural course of ATN Last 18 months: 2813 articles
RENAL FAILURE IN ICU. Jo-Ann Vosloo Department Critical Care SBAH
RENAL FAILURE IN ICU Jo-Ann Vosloo Department Critical Care SBAH DEFINITION: RIFLE criteria Criteria for initiation of RRT Modes of RRT (options) CRRT = continuous renal replacement therapy SCUF : Ultra-filtration
CRRT Fundamentals Pre- and Post- Test Answers. AKI & CRRT 2017 Practice Based Learning in CRRT
CRRT Fundamentals Pre- and Post- Test Answers AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling
[1] Levy [3] (odds ratio) 5.5. mannitol. (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP)
![[1] Levy [3] (odds ratio) 5.5. mannitol. (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP)](/thumbs/92/109602349.jpg "[1] Levy [3] (odds ratio) 5.5. mannitol. (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP)")
[1] Levy [3] 183 174 (odds ratio) 5.5 Woodrow [1] 1956 1989 mannitol (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP) McCarthy [2] 1970 1990 insulin-like growth factor-1 (IGF-1) ANP 92
ACUTE KIDNEY INJURY. Stuart Linas U. Colorado SOM
ACUTE KIDNEY INJURY Stuart Linas U. Colorado SOM Marked increases in incidence of dialysis-requiring AKI in last decade JASN 24 37 2013 Question 1 Of patients who recover from an episode of AKI, what percentage
Accelerated Venovenous Hemofiltration: Early Technical and Clinical Experience
Accelerated Venovenous Hemofiltration: Early Technical and Clinical Experience Casey N. Gashti, MD, Susana Salcedo, MD, Virginia Robinson, RN, and Roger A. Rodby, MD Background: Renal replacement therapies
Fluid balance in Critical Care
Fluid balance in Critical Care By Dr HP Shum Nephrologist and Critical Care Physician Department of Intensive Care, PYNEH Fluid therapy is a critical aspect of initial acute resuscitation in critically
What is the right fluid to use?
What is the right fluid to use? L McIntyre Associate Professor, University of Ottawa Senior Scientist, Ottawa Hospital Research Institute Centre for Transfusion Research CCCF, November 2, 2016 Disclosures
When to start a renal replacement therapy in acute kidney injury (AKI) patients: many irons in the fire
Editorial Page 1 of 4 When to start a renal replacement therapy in acute kidney injury (AKI) patients: many irons in the fire Stefano Romagnoli 1,2, Zaccaria Ricci 3 1 Department of Anesthesia and Critical
EUROANESTHESIA 2008 Copenhagen, Denmark, 31 May - 3 June RC3
RENAL REPLACEMENT THERAPY: STATE OF THE ART EUROANESTHESIA 2008 Copenhagen, Denmark, 31 May - 3 June 2008 12RC3 WILFRED DRUML Department of Medicine, Division of Nephrology Medical University of Vienna
Prevention of Acute Renal Failure Role of vasoactive drugs and diuretic agents
of Acute Renal Failure Role of vasoactive drugs and diuretic agents Armand R.J. Girbes Prof.dr. A.R.J. Girbes Chairman department of Intensive Care VU University Medical Center Netherlands (Failure of)
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,
Drug dosing in patients with acute kidney injury
Drug dosing in patients with acute kidney injury They don t know what they are doing Jan Jan T. T. Kielstein Department of of Nephrology and and Hypertension Medical School School Hannover Drug dosing
Renal replacement therapy in Pediatric Acute Kidney Injury
Renal replacement therapy in Pediatric Acute Kidney Injury ASCIM 2014 Dr Adrian Plunkett Consultant Paediatric Intensivist Birmingham Children s Hospital, UK Aims of the presentation Important topic: AKI
Initiation Strategies for Renal Replacement Therapy in ICU
Initiation Strategies for Renal Replacement Therapy in ICU The Artificial Kidney Initiation in Kidney Injury trial AKIKI Stéphane Gaudry Réanimation médico-chirurgicale Hôpital Louis Mourier, Colombes
Prof Patrick Honoré,MD, PhD,FCCM Intensivist-Nephrologist
Pro-Con Debate on High Volume Hemofiltration :Burial or Ressurection? The Pro Position 1.-Why Moving From Dose To Membranes? 4.-AN69 Oxiris LPS Adsorptive Membranes in Sepsis 2.- High Cut-Off Membranes
Renal replacement therapy in acute kidney injury
6 February 2009 CONTENTS Renal replacement therapy in acute kidney injury S Jithoo Commentator: CL Quantock Moderator: LW Drummond INTRODUCTION... 3 WHAT IS RENAL REPLACEMENT THERAPY?... 3 MODES OF RENAL
Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care
CRRT. Sustained low efficiency daily dialysis, SLEDD. Sustained low efficiency daily diafiltration, SLEDD-f. inflammatory cytokine IL-1 IL-6 TNF-
RRT, renal replacement therapy IHDCRRT CRRT 24 CRRT Sustained low efficiency daily dialysis, SLEDD 6 ~ 12 300 Sustained low efficiency daily diafiltration, SLEDD-f inflammatory cytokine IL-1 IL-6 TNF-
Management of Acute Kidney Injury in the Neonate. Carolyn Abitbol, M.D. University of Miami Miller School of Medicine / Holtz Children s Hospital
Management of Acute Kidney Injury in the Neonate Carolyn Abitbol, M.D. University of Miami Miller School of Medicine / Holtz Children s Hospital Objectives Summarize the dilemmas in diagnosing & recognizing
NO ADDED MORTALITY BENEFIT FROM CURRENT APPROACHES TO RENAL REPLACEMENT THERAPY IN ICU PATIENTS
NO ADDED MORTALITY BENEFIT FROM CURRENT APPROACHES TO RENAL REPLACEMENT THERAPY IN ICU PATIENTS *Helmut Schiffl Department of Internal Medicine IV, University Hospital Munich, Munich, Germany *Correspondence
Une promenade dans l'épidémiologie de l'insuffisance rénale aiguë en quatre étapes
Une promenade dans l'épidémiologie de l'insuffisance rénale aiguë en quatre étapes Fernando Liaño Hospital Universitario Ramón y Cajal Madrid, España Genéve, 14-12-2012 Une promenade dans l'épidémiologie
Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada
Vasopressors in Septic Shock Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada Echocardiogram: EF=25% 57 y.o. female, pneumonia, shock Echocardiogram: EF=25% 57 y.o.
CRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018
CRRT for the Experience User 1 Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018 Disclosures I have no actual or potential conflict of interest
Acute Kidney Injury. Arvind Bagga All India Institute of Medical Sciences New Delhi, India
Acute Kidney Injury Arvind Bagga All India Institute of Medical Sciences New Delhi, India What is AKI? Sudden loss of renal function, over hrdays, with derangement(s) in fluid balance, acid base & electrolytes
Recent advances in CRRT
Recent advances in CRRT JAE IL SHIN, M.D., Ph.D. Department of Pediatrics, Severance Children s Hospital, Yonsei University College of Medicine, Seoul, Korea Pediatric AKI epidemiology and demographics
PD In Acute Kidney Injury. February 7 th -9 th, 2013
PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of
CRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018
CRRT Fundamentals Pre- and Post- Test AKI & CRRT Conference 2018 Question 1 Which ONE of the following statements regarding solute clearance in CRRT is MOST correct? A. Convective and diffusive solute
Fluid Treatments in Sepsis: Meta-Analyses
Fluid Treatments in Sepsis: Recent Trials and Meta-Analyses Lauralyn McIntyre MD, FRCP(C), MSc Scientist, Ottawa Hospital Research Institute Assistant Professor, University of Ottawa Department of Epidemiology
End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology
End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated
Fluids in ICU. JMO teaching 5th July 2016
Fluids in ICU JMO teaching 5th July 2016 Objectives Physiology of fluid infusion History of fluid resuscitation Physiology of fluid resuscitation Types of resuscitation fluid The ideal resuscitation fluid
Contrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
Pediatric Continuous Renal Replacement Therapy
Pediatric Continuous Renal Replacement Therapy Farahnak Assadi Fatemeh Ghane Sharbaf Pediatric Continuous Renal Replacement Therapy Principles and Practice Farahnak Assadi, M.D. Professor Emeritus Department
Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London
Acute Kidney Injury Adding Insult to Injury Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London Content 1. Brief review of AKI and its impact 2. Comments on the
CRRT: QUALITY MANAGEMENT SYSTEMS
CRRT: QUALITY MANAGEMENT SYSTEMS Javier A. Neyra, MD, MSCS Director, Acute Care Nephrology & CRRT Program University of Kentucky Medical Center Disclosures and Funding Disclosures Consulting agreement
Sepsis Management Update 2014
Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma
Predictive and prognostic value of RIFLE classification on ICU Patients with acute kidney injury treated with continuous renal replacement therapy
Predictive and prognostic value of RIFLE classification on ICU Patients with acute kidney injury treated with continuous renal replacement therapy Walid M Afifi, Haitham E Mohamed 1, Mohamed Abdelzaher
Blood purification in sepsis
Blood purification in sepsis Joannes-Boyau O Dept of anesthesiology and intensive care, University Hospital of Bordeaux, France 1 Types of Blood Purification hemofilters regular pore size (MW < 40,000D)
Norepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome
Norepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome Disclosure I have no conflicts of interest to disclose Name: Margarita Taburyanskaya Title: PharmD, PGY1 Pharmacy Practice Resident
Can We Achieve Precision Solute Control with CRRT?
Can We Achieve Precision Solute Control with CRRT? Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference February, 2019 Disclosures I have no actual or potential
higher dose with progress in technical equipment. Continuous Dialysis: Dose and Antikoagulation. prescribed and delivered
1 2 Continuous Dialysis: Dose and Antikoagulation higher dose with progress in technical equipment Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure.
Acute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
Acute Kidney Injury; get the basics right first!
Acute Kidney Injury; get the basics right first! Dr Christopher Wong, Consultant Nephrologist and General Physician, University Hospital Aintree (UHA), Liverpool, UK Acute kidney injury (AKI) Why a new
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
Intravenous Fluid Therapy in Critical Illness
Intravenous Fluid Therapy in Critical Illness GINA HURST, MD DIVISION OF EMERGENCY CRITICAL CARE HENRY FORD HOSPITAL DETROIT, MI Objectives Establish goals of IV fluid therapy Review fluid types and availability
Nutrition in Acute Kidney Injury Enrico Fiaccadori
Nutrition in Acute Kidney Injury Enrico Fiaccadori Nephrology Dept. Parma University Medical School Parma, Italy Diagnosis, epidemiology and prognostic impact of proteinenergy wasting (PEW) in AKI Pathogenetic
Sepsis: Identification and Management in an Acute Care Setting
Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES
FLUID RESUSCITATION SUMMARY
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
Dialyzing challenging patients: Patients with hepato-renal conditions
Dialyzing challenging patients: Patients with hepato-renal conditions Nidyanandh Vadivel MD Medical Director for Living kidney Donor and Pancreas Transplant Programs Swedish Organ Transplant, Seattle Acute
Management of Advanced Systolic Heart Failure. Robert W. Hull MD FACC Associate Professor of Medicine West Virginia University
Management of Advanced Systolic Heart Failure Robert W. Hull MD FACC Associate Professor of Medicine West Virginia University American College of Cardiology Foundation (ACCF) American Heart Association
Septic AKI in ICU patients
Septic AKI in ICU patients Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum Berlin, Germany achim.joerres@charite.de Agenda Epidemiology
Impact of Fluids in Children with Acute Lung Injury
Impact of Fluids in Children with Acute Lung Injury Canadian Critical Care Forum Toronto, Canada October 27 th, 2015 Adrienne G. Randolph, MD, MSc Critical Care Division, Department of Anesthesia, Perioperative
Acute kidney injury (AKI), previously
Concise Definitive Review Jonathan E. Sevransky, MD, MHS, Section Editor Acute kidney injury in the intensive care unit: An update and primer for the intensivist Paula Dennen, MD; Ivor S. Douglas, MD;
What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14
What is the Role of Albumin in Sepsis? An Evidenced Based Affair Justin Belsky MD PGY3 2/6/14 Microcirculation https://www.youtube.com/watch?v=xao1gsyur7q Capillary Leak in Sepsis Asking the RIGHT Question
Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,
Fluids in Sepsis Less is more Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth, FRACGP @drsenthi Summary Discussion of the evidence for/against fluid resuscitation in septic shock
Fluid resuscitation in specific patient populations: sepsis and traumatic brain injury
Fluid resuscitation in specific patient populations: sepsis and traumatic brain injury John A Myburgh MBBCh PhD FCICM UNSW Professor of Critical Care Medicine The George Institute for Global Health University
Severity and Outcome of Acute Kidney Injury According to Rifle Criteria in the Intensive Care Unit
BANTAO Journal 2010; 8 (1): 35-39 BJ BANTAO Journal Original Article Severity and Outcome of Acute Kidney Injury According to Rifle Criteria in the Intensive Care Unit Albana Gjyzari 1, Elizana Petrela
Comment on infusion solutions containing HES
Comment on infusion solutions containing HES The European Medicines Agency (EMA) published on 14 June 2013 Pharmacovigilance Risk Assessment Committee (PRAC) recommends suspending marketing authorisations
Large RCT s s in RRT : What can be learnt for nursing?
Large RCT s s in RRT : What can be learnt for nursing? Ian Baldwin Dept. of Intensive Care, Austin Hospital Adjunct Professor, RMIT University CRRT 2011 Hilton Bayfront, February 22-25 SanDiego Key Hypothesis
Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health
Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different
ESPEN Congress Vienna Nutritional implications of renal replacement therapy in ICU Nutritional consequences of RRT. E. Fiaccadori (Italy)
ESPEN Congress Vienna 2009 Nutritional implications of renal replacement therapy in ICU Nutritional consequences of RRT E. Fiaccadori (Italy) Nutritional consequences of RRT Enrico Fiaccadori Internal
By; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital
By; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital Introduction The significance of nutrition in hospital setting (especially the ICU) cannot be overstated.
Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018
Tailored Volume Resuscitation in the Critically Ill is Achievable Heath E Latham, MD Associate Professor Fellowship Program Director Pulmonary and Critical Care Objectives Describe the goal of resuscitation
RRT in Advanced Heart Failure and Liver Failure When to start and when to stop?
Critical Care Medicine Apollo Hospitals RRT in Advanced Heart Failure and Liver Failure When to start and when to stop? Ramesh Venkataraman, AB (Int. Med), AB (CCM) Senior Consultant, Critical Care Medicine
Getting smart with fluids in the critically ill. NOR AZIM MOHD YUNOS Jeffrey Cheah School of Medicine & Health Sciences Monash University Malaysia
Getting smart with fluids in the critically ill NOR AZIM MOHD YUNOS Jeffrey Cheah School of Medicine & Health Sciences Monash University Malaysia Isotonic Solutions and Major Adverse Renal Events Trial